| Product Code: ETC12974767 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Angelman Syndrome Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Angelman Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Angelman Syndrome Market - Industry Life Cycle |
3.4 Israel Angelman Syndrome Market - Porter's Five Forces |
3.5 Israel Angelman Syndrome Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Israel Angelman Syndrome Market Revenues & Volume Share, By Patient Age Group, 2021 & 2031F |
3.7 Israel Angelman Syndrome Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Angelman Syndrome Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Israel Angelman Syndrome Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Angelman Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about Angelman Syndrome in Israel |
4.2.2 Advancements in medical research and technology for diagnosis and treatment |
4.2.3 Supportive government policies and funding for rare disease research |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals for Angelman Syndrome |
4.3.2 High costs associated with diagnosis, treatment, and specialized care for Angelman Syndrome patients |
5 Israel Angelman Syndrome Market Trends |
6 Israel Angelman Syndrome Market, By Types |
6.1 Israel Angelman Syndrome Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Angelman Syndrome Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 Israel Angelman Syndrome Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.1.4 Israel Angelman Syndrome Market Revenues & Volume, By Antiepileptic Drugs, 2021 - 2031F |
6.1.5 Israel Angelman Syndrome Market Revenues & Volume, By Behavioral Therapy, 2021 - 2031F |
6.2 Israel Angelman Syndrome Market, By Patient Age Group |
6.2.1 Overview and Analysis |
6.2.2 Israel Angelman Syndrome Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.2.3 Israel Angelman Syndrome Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3 Israel Angelman Syndrome Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Angelman Syndrome Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.3.3 Israel Angelman Syndrome Market Revenues & Volume, By Oral, 2021 - 2031F |
6.4 Israel Angelman Syndrome Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Angelman Syndrome Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Israel Angelman Syndrome Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Israel Angelman Syndrome Market Revenues & Volume, By Rehabilitation Centers, 2021 - 2031F |
6.5 Israel Angelman Syndrome Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Angelman Syndrome Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
6.5.3 Israel Angelman Syndrome Market Revenues & Volume, By Online Sales, 2021 - 2031F |
7 Israel Angelman Syndrome Market Import-Export Trade Statistics |
7.1 Israel Angelman Syndrome Market Export to Major Countries |
7.2 Israel Angelman Syndrome Market Imports from Major Countries |
8 Israel Angelman Syndrome Market Key Performance Indicators |
8.1 Number of clinical trials and research studies focused on Angelman Syndrome in Israel |
8.2 Percentage increase in early diagnosis rates of Angelman Syndrome |
8.3 Number of support groups and advocacy organizations dedicated to Angelman Syndrome in Israel |
9 Israel Angelman Syndrome Market - Opportunity Assessment |
9.1 Israel Angelman Syndrome Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Israel Angelman Syndrome Market Opportunity Assessment, By Patient Age Group, 2021 & 2031F |
9.3 Israel Angelman Syndrome Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Angelman Syndrome Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Israel Angelman Syndrome Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Angelman Syndrome Market - Competitive Landscape |
10.1 Israel Angelman Syndrome Market Revenue Share, By Companies, 2024 |
10.2 Israel Angelman Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here